Slate Bio

Slate Bio Inc. is a privately held pre-clinical stage biotechnology company. We work to create therapies that restore the body’s natural immunological response in various diseases using bifunctional IL233 cytokine, thereby providing users with a second independent synergistic pathway that has greater tissue selectivity and improved pharmacodynamics, at lower doses and without side-effects.